Peptide questions · Eloralintide

What is eloralintide stacked with?

Reviewed Evidence: ModeratePublished by PepVault

The library lists eloralintide as commonly stacked with tirzepatide, semaglutide and retatrutide, and it holds notes on one of the three pairings, resting on randomized trials.

This page describes what the library holds about each pairing. It recommends none of them.

Eloralintide with tirzepatide

What each does. Eloralintide: Once-weekly, long-acting agonist of the amylin receptor, the receptor for amylin, the fullness hormone the pancreas releases with insulin. Tirzepatide: Dual GIP/GLP-1 receptor agonist.

“Eloralintide with tirzepatide”, in the eloralintide notes (randomized trial)

Eloralintide beside Tirzepatide: Phase 2b (NCT06603571; 367 adults with obesity and type 2 diabetes; separate injections): eloralintide 9 mg + tirzepatide 15 mg −23.3%, tirzepatide 15 mg −14.8%, eloralintide alone up to −12.3%, placebo −3.0%; A1C fell up to 2.9 points on the pair. Stopping for side effects: 10.8% to 27.0% on the pairs vs 2.9% on tirzepatide alone; Lilly plans a slower step-up in phase 3 (Lilly, Sep-30-2026; presented at EASD, not yet a paper).

The eloralintide interaction note

Eloralintide beside Tirzepatide: It is not a GLP-1, and Lilly is testing it on top of tirzepatide (EloraTZP), but the GI side effects add up in the pair.

A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track eloralintide in PepVault

Log every compound in your stack, each on its own schedule, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Eloralintide with semaglutide

What each does. Eloralintide: Once-weekly, long-acting agonist of the amylin receptor, the receptor for amylin, the fullness hormone the pancreas releases with insulin. Semaglutide: GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves glucose metabolism.

Beyond listing semaglutide as a common stack, the library says nothing about running it with eloralintide.

Eloralintide with retatrutide

What each does. Eloralintide: Once-weekly, long-acting agonist of the amylin receptor, the receptor for amylin, the fullness hormone the pancreas releases with insulin. Retatrutide: Triple GIP/GLP-1/glucagon receptor agonist.

Beyond listing retatrutide as a common stack, the library says nothing about running it with eloralintide.

Questions people ask

What is eloralintide stacked with?

The library lists eloralintide as commonly stacked with tirzepatide, semaglutide and retatrutide, and it holds notes on one of the three pairings, resting on randomized trials.

What does the library say about eloralintide with tirzepatide?

On eloralintide with tirzepatide: it holds one research note on the pair, starting with “Eloralintide with tirzepatide”. An interaction note names the pair. PepVault compares the two on its tirzepatide vs eloralintide page. It recommends no pairing.

More on eloralintide

Track it in the app

PepVault for iPhone

Track eloralintide in PepVault

Log every compound in your stack, each on its own schedule, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo